Pfizer: Unaudited Financial Results For The Quarter And Half Year EndedSeptember 30 2022 | Value Research

Pfizer: Unaudited Financial Results For The Quarter And Half Year EndedSeptember 30 2022

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the unaudited financial results for the quarter andhalf year ended September 30 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today that commenced at 2.15 p.m. andconcluded at 4.00 p.m.Also please find enclosed the Limited Review Report by our Auditors M/s. B S R & Co. LLP in respect of the above results.Please take the above on record

Click here to view PDF


Other Categories